Stockreport

Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra-Strength" 40U Formulation of Jeuveau® [Yahoo! Finance]

Evolus, Inc.  (EOLS) 
Last evolus, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: us.evolis.com/investor-relations
PDF Data showed duration effect of 26 weeks, or 6 months, based on a = 1-point Glabellar Line Scale (GLS) improvement and return to baseline value using the Global Aestheti [Read more]